Contract 75A50121C00073
Elusys Therapeutics Inc · Department Of Health And Human Services · August 6, 2021
Elusys Therapeutics Inc was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on August 6, 2021 for $79.95 million of work in pharmaceutical preparation manufacturing. Performance is in Parsippany, NJ. It was awarded under full and open competition. The contract has been modified 6 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 12, 2024.
Contract details
- PIID
- 75A50121C00073
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Parsippany, NJ
- First action
- August 6, 2021
- Latest action
- March 12, 2024
Description
MANUFACTURE AND DELIVERY OF ANTHIM (OBILTOXAXIMAB)600MG/6ML INJECTION, AN ANTHRAX ANTITOXIN COUNTERMEASURE
Modification timeline
-
March 12, 2024Mod P00006$-86.0K
-
April 5, 2023Mod P00005$-830.8K
-
April 7, 2022Mod P00004REMOVE IPP CLAUSE$0
-
April 6, 2022Mod P00003ODER THE TRANSFER OF ALL CLIN 0003 BDS TO GFE THEN ORDER THE CONVERSION OF ALL BDS TO FDP UNDER CLIN 0006. ALL FDP WILL BE ORDERED SHIPPED IN UP TO 8 SHIPMENTS$30.87M
-
January 10, 2022Mod P00002DEFINITIZE LETTER CONTRACT$0
-
November 10, 2021Mod P00001EO14042 LETTER CONTRACT ADD FAR 52.223-99 ENSURING ADEQUATE COVID-19 SAFETY PROTOCOLS FOR FEDERAL CONTRACTORS (OCT 2021)(DEVIATION)$0
-
August 6, 2021Base awardANTHIM LETTER CONTRACT$50.00M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Four Points Technology, L.L.C. | Department Of Health And Human Services | March 31, 2026 | $246.6K |
| Astrazeneca Pharmaceuticals Lp | Department Of Health And Human Services | March 31, 2026 | $122.8K |
| Ase Direct, Inc. | Department Of Health And Human Services | March 30, 2026 | $49.0K |
| Mckesson Corporation | Department Of Health And Human Services | March 30, 2026 | $9.00M |
| Emergent Biosolutions Canada Inc | Department Of Health And Human Services | March 30, 2026 | $256.40M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 27, 2026 | $92.33M |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50121C00073?
Contract 75A50121C00073 is a federal contract awarded to Elusys Therapeutics Inc by Department Of Health And Human Services on August 6, 2021 for $79.95 million of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 6 times since the base award.
Who won contract 75A50121C00073?
Elusys Therapeutics Inc won contract 75A50121C00073 from Department Of Health And Human Services.
How much is contract 75A50121C00073 worth?
Contract 75A50121C00073 has obligated $79.95 million to date.